Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glycosylated Hemoglobin and Its Correlations With Electrophysiological Studies and Gait Performance in Diabetic Polyneuropathy Patients

NCT05457192 is registered in ClinicalTrials.gov with Shereen Saad Eldin Mohamed Ali as lead sponsor.

NCT NCT05457192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05457192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glycosylated Hemoglobin and Its Correlations With Electrophysiological Studies and Gait Performance in Diabetic Polyneuropathy Patients
Lead sponsor
Shereen Saad Eldin Mohamed Ali
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2022
Completion date
October 31, 2022
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic polyneuropathy